CORRESP 1 filename1.htm

govx20250627_corresp.htm

GeoVax Labs, Inc.

1900 Lake Park Drive

Suite 380

Smyrna, Georgia 30080

(678) 384-7220

June 27, 2025

VIA EDGAR

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Re: GeoVax Labs, Inc. Amendment No. 1 to Registration Statement on Form S-1 File No. 333-288085

Ladies and Gentlemen:

In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-288085) filed with the U.S. Securities and Exchange Commission on June 26, 2025, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Monday, June 30, 2025 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act.

If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.

		Very truly yours,
		GeoVax Labs, Inc.
	By:	/s/ Mark W. Reynolds
		Mark W. Reynolds
		Chief Financial Officer